Extended Prophylaxis for Venous Thromboembolism in Acute Medically Ill Patients
Best Practices for Implementing Venous Thromboembolism Prophylaxis Across the Continuum of Care
ByPaul P. Dobesh, PharmD,Tania Ahuja, PharmD,George A. Davis, PharmD,Hugh Fatodu, MBA, RPh,William H. Francis, MBA, RPh,Frank P. Hull, MD,Gary L. Johnson, MD, MS, MBA,Joshua D. Lenchus, DO, BSPharm,Jacqueline Glee Lenoir, PharmD,Claudette McPherson, RN, BSN,Jeffrey Nemeth, PharmD, MPA,Ralph J. Riello III, PharmD
The Use of Betrixaban for Extended Prophylaxis of Venous Thromboembolism Events in Hospitalized, High-Risk Patients
ByPaul P. Dobesh, PharmD,Tania Ahuja, PharmD,George A. Davis, PharmD,Hugh Fatodu, MBA, RPh,William H. Francis, MBA, RPh,Frank P. Hull, MD,Gary L. Johnson, MD, MS, MBA,Joshua D. Lenchus, DO, BSPharm,Jacqueline Glee Lenoir, PharmD,Claudette McPherson, RN, BSN,Jeffrey Nemeth, PharmD, MPA,Ralph J. Riello III, PharmD
Venous Thromboembolism in Acute Medically Ill Patients: Identifying Unmet Needs and Weighing the Value of Prophylaxis
ByPaul P. Dobesh, PharmD,Tania Ahuja, PharmD,George A. Davis, PharmD,Hugh Fatodu, MBA, RPh,William H. Francis, MBA, RPh,Frank P. Hull, MD,Gary L. Johnson, MD, MS, MBA,Joshua D. Lenchus, DO, BSPharm,Jacqueline Glee Lenoir, PharmD,Claudette McPherson, RN, BSN,Jeffrey Nemeth, PharmD, MPA,Ralph J. Riello III, PharmD
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Durvalumab Plus EV Before Surgery in Cisplatin-Ineligible MIBC
2
ObesityWeek 2026: Studies Map GLP-1 Access Gaps, Obesity's Costs
3
5 Things to Know About Diabetes-Related Eye Disease Awareness Month
4
Payers, Eosinophil Thresholds Shape Who Gets a COPD Biologic
5